Related Experiment Video
Updated: Jun 3, 2026

12:31
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
Production of a Human Antibody Library in the Phage-Display Vector pSEX81
M Welschof1, M Little, H Dörsam
1Department of Transplantation Immunology, University of Heidelberg, Germany.
Methods in Molecular Medicine
|March 11, 2011
Summary
Human recombinant antibodies offer advantages over animal-derived ones, overcoming limitations of traditional hybridoma and Epstein-Barr virus (EBV) methods for clinical applications.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Human monoclonal antibodies (MAbs) are preferred for clinical use due to reduced hypersensitivity and immune complex formation compared to animal MAbs.
- Classical production methods like hybridoma and Epstein-Barr virus (EBV) transformation face challenges such as cell line instability and low antibody yields.
- Immunizing humans for antibody production can be problematic for certain antigens.
Purpose of the Study:
- To explore human recombinant antibody production as a superior alternative to traditional methods.
- To leverage recombinant DNA technology for generating diverse human antibody libraries.
- To overcome the limitations associated with classical human MAb production techniques.
Main Methods:
- Utilizing recombinant DNA technology to clone human antibody genes into expression vectors.
- Generating human antibody expression libraries.
- Amplifying and recombining immunoglobulin G (IgG) repertoires from immunized donors.
- Pooling naive immunoglobulin M (IgM) repertoires from unimmunized donors to create universal libraries.
- Developing "semisynthetic" antibody libraries to increase complexity.
Main Results:
- Recombinant DNA technology enables the creation of human antibody expression libraries.
- Different strategies, including repertoire amplification and pooling of naive repertoires, have been employed to generate diverse antibody libraries.
- Semisynthetic approaches further enhance the complexity and potential utility of these libraries.
Conclusions:
- Human recombinant antibody production presents a promising alternative to conventional methods.
- Recombinant DNA technology facilitates the generation of diverse human antibody repertoires for various applications.
- Advanced library construction techniques like semisynthesis offer enhanced potential for discovering clinically relevant antibodies.

